Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
2 Growth Stocks Wall Street Analysts Think Can Double in Value Motley Fool - Wed Jul 19, 2023

Is now a good time to buy these promising healthcare stocks?

VRDN : 14.60 (-3.69%)
DNA : 0.8649 (-6.46%)
Why Shares of Viridian Therapeutics Are Falling Tuesday Motley Fool - Tue Jul 11, 2023

The company announced preliminary trial results for its lead therapy.

HZNP : 116.30 (+0.04%)
VRDN : 14.60 (-3.69%)
Why These 2 Nasdaq Biotech Stocks Fell Hard Tuesday Morning Motley Fool - Tue Jul 11, 2023

Broader markets seemed likely to start out on a positive note despite these two outliers.

COMP : 3.24 (-0.61%)
$NASX : 15,282.01 (-2.05%)
VRDN : 14.60 (-3.69%)
IOVA : 11.31 (-3.50%)
Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Misses Revenue Estimates Zacks - Tue May 9, 2023

Viridian Therapeutics, Inc. (VRDN) delivered earnings and revenue surprises of -61% and 67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

VRDN : 14.60 (-3.69%)
SPRO : 1.4000 (-4.76%)
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Lags Revenue Estimates Zacks - Wed Mar 8, 2023

Viridian Therapeutics, Inc. (VRDN) delivered earnings and revenue surprises of -56.94% and 85.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

VRDN : 14.60 (-3.69%)
ETON : 3.19 (+4.25%)
Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates Zacks - Mon Mar 6, 2023

Cara (CARA) delivered earnings and revenue surprises of -69.70% and 76.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CARA : 0.6610 (-4.20%)
VRDN : 14.60 (-3.69%)
Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates Zacks - Thu Mar 2, 2023

Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

SYRS : 4.54 (-3.81%)
VRDN : 14.60 (-3.69%)
Wall Street Analysts Predict an 89% Upside in Viridian Therapeutics, Inc. (VRDN): Here's What You Should Know Zacks - Thu Nov 17, 2022

The mean of analysts' price targets for Viridian Therapeutics, Inc. (VRDN) points to an 89.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

VRDN : 14.60 (-3.69%)
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates Zacks - Mon Nov 14, 2022

Viridian Therapeutics, Inc. (VRDN) delivered earnings and revenue surprises of 1.15% and 131.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

VRDN : 14.60 (-3.69%)
LVTX : 2.71 (-4.24%)
Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates Zacks - Thu Nov 10, 2022

Rani Therapeutics Holdings, Inc. (RANI) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

RANI : 7.07 (+16.86%)
VRDN : 14.60 (-3.69%)

Barchart Exclusives

Bull or Bear? Where Corn, Wheat, and Soybean Price are Headed Barchart - 1 hour ago
Darin Newsom joins Bryce Doeschot on Market Journal to discuss the corn, wheat, soybean, and cattle markets. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot